Anti-tumor activities of the new oral pan-RAF inhibitor, TAK-580, used as monotherapy or in combination with novel agents in multiple myeloma

Many RAS pathway inhibitors, including pan-RAF inhibitors, have shown significant anti-tumor activities in both solid and hematological tumors. The pan-RAF inhibitor, TAK-580, is a representative of the novel RAF inhibitors that act by disrupting RAF homo- or heterodimerization. In this study, we ex...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Suzuki, Rikio, Kitamura, Yuka, Nakamura, Yoshihiko, Akashi, Hibiki, Ogawa, Yoshiaki, Kawada, Hiroshi, Ando, Kiyoshi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2020
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646837/
https://ncbi.nlm.nih.gov/pubmed/33216827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27775
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items